NO20072498L - Behandling eller forebyggelse av blodende virale infeksjoner med immunmodulatorforbindelse - Google Patents

Behandling eller forebyggelse av blodende virale infeksjoner med immunmodulatorforbindelse

Info

Publication number
NO20072498L
NO20072498L NO20072498A NO20072498A NO20072498L NO 20072498 L NO20072498 L NO 20072498L NO 20072498 A NO20072498 A NO 20072498A NO 20072498 A NO20072498 A NO 20072498A NO 20072498 L NO20072498 L NO 20072498L
Authority
NO
Norway
Prior art keywords
bleeding
treatment
prevention
viral infections
immunomodulator compound
Prior art date
Application number
NO20072498A
Other languages
English (en)
Norwegian (no)
Inventor
Alfred R Rudolph
Cynthia W Tuthill
Eric C Mossel
Original Assignee
Sciclone Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sciclone Pharmaceuticals Inc filed Critical Sciclone Pharmaceuticals Inc
Publication of NO20072498L publication Critical patent/NO20072498L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20072498A 2004-10-27 2007-05-15 Behandling eller forebyggelse av blodende virale infeksjoner med immunmodulatorforbindelse NO20072498L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62202204P 2004-10-27 2004-10-27
PCT/US2005/038834 WO2006047702A2 (en) 2004-10-27 2005-10-27 Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds

Publications (1)

Publication Number Publication Date
NO20072498L true NO20072498L (no) 2007-05-15

Family

ID=36228480

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072498A NO20072498L (no) 2004-10-27 2007-05-15 Behandling eller forebyggelse av blodende virale infeksjoner med immunmodulatorforbindelse

Country Status (19)

Country Link
US (1) US8193152B2 (de)
EP (1) EP1814566B1 (de)
JP (1) JP4874985B2 (de)
KR (1) KR20070070202A (de)
CN (1) CN101048171B (de)
AT (1) ATE475426T1 (de)
AU (1) AU2005299609A1 (de)
BR (1) BRPI0517401A (de)
CA (1) CA2585457A1 (de)
DE (1) DE602005022612D1 (de)
EA (1) EA012342B1 (de)
ES (1) ES2350087T3 (de)
IL (1) IL182710A (de)
MX (1) MX2007005092A (de)
NO (1) NO20072498L (de)
NZ (1) NZ555322A (de)
SG (1) SG163601A1 (de)
UA (1) UA92727C2 (de)
WO (1) WO2006047702A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006116053A1 (en) * 2005-04-22 2006-11-02 Sciclone Pharmaceuticals, Inc. Immunomodulator compounds as vaccine enhancers
MX2009008641A (es) * 2007-02-13 2009-09-14 Sciclone Pharmaceuticals Inc Composiciones para el tratamiento o prevencion del deterioro, lesion o daño a tejido debido a enfermedad de las mucosas.
EP2675272A4 (de) * 2011-02-09 2015-03-11 Sciclone Pharmaceuticals Inc Thymosin-alpha-peptid zur prävention, linderung und behandlung von infektionen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744452A (en) * 1995-11-28 1998-04-28 Edward T. Wei γ-L-glutamyl containing immunomodulator compounds and methods therewith
US5916878A (en) * 1995-11-28 1999-06-29 Edward T. Wei γ-glutamyl and β-aspartyl containing immunomodulator compounds and methods therewith
SG169362A1 (en) 2004-05-14 2011-03-30 Sciclone Pharmaceuticals Inc Treatment or prevention of respiratory viral infections with immunomodulator compounds
UA12948U (en) 2005-07-11 2006-03-15 Inst Of Veterinary Medicine Uk Associated inactivated concentrated serdosan vaccine against colibacteriosis, edematous disease, pasteurellosis, salmonellosis, and anaerobic enterotoxicemia of pigs

Also Published As

Publication number Publication date
DE602005022612D1 (de) 2010-09-09
IL182710A (en) 2012-04-30
NZ555322A (en) 2009-02-28
WO2006047702A2 (en) 2006-05-04
KR20070070202A (ko) 2007-07-03
JP4874985B2 (ja) 2012-02-15
MX2007005092A (es) 2007-07-04
EA012342B1 (ru) 2009-10-30
BRPI0517401A (pt) 2008-10-14
ATE475426T1 (de) 2010-08-15
SG163601A1 (en) 2010-08-30
WO2006047702A3 (en) 2006-07-20
US20090143313A1 (en) 2009-06-04
AU2005299609A1 (en) 2006-05-04
CN101048171A (zh) 2007-10-03
EP1814566B1 (de) 2010-07-28
JP2008518031A (ja) 2008-05-29
EP1814566A4 (de) 2008-05-07
US8193152B2 (en) 2012-06-05
CA2585457A1 (en) 2006-05-04
IL182710A0 (en) 2007-07-24
UA92727C2 (ru) 2010-12-10
ES2350087T3 (es) 2011-01-18
CN101048171B (zh) 2011-02-09
EA200700878A1 (ru) 2007-10-26
EP1814566A2 (de) 2007-08-08

Similar Documents

Publication Publication Date Title
LT4445900T (lt) Terapiniai junginiai, skirti živ viruso infekcijai gydyti
EA200900156A1 (ru) Пиридазиновое соединение (варианты), способ его получения (варианты), способ лечения или профилактики инфекционного вирусного гепатита с с его помощью, композиция и лекарственное средство на его основе
NO20052580D0 (no) Blandinger for behandling av infeksjon av Flavivirida viruser
NO20070988L (no) Vaksine for forebygging og behandling av HIV-infeksjon
BRPI0612309B8 (pt) compostos e composições farmacêuticas antivirais
AU2003291885A1 (en) Compounds and methods for the treatment or prevention of flavivirus infections
CL2011000571A1 (es) Uso de una combinacion de: a) un compuesto de formula (1) o una sal farmaceuticamente aceptable del mismo, b) interferon alfa y c) ribavirina para preparar un medicamento util para el tratamiento de una infeccion viral de la hepatitis c (hcv) o para aliviar uno o mas sintomas de la misma.
NO20064547L (no) Fremgangsmater for behandling av HIV infeksjon
NO20073765L (no) Forbindelser for behandling av flaviviridae
ATE534652T1 (de) Phosphono-pent-2-en-1-yl-nukleoside und analoga
NO20065075L (no) Ikke-nukleosidbaserte revers-transkriptase-inhibitorer.
ECSP045397A (es) 6-ALQUILIDEN-PENEMS BICÍCLICOS COMO INHIBIDORES DE LAS b-LACTAMASAS
NO20044548L (no) Fremgangsmate for fremstilling av 6-alkaliden-penemderivater
NO20072498L (no) Behandling eller forebyggelse av blodende virale infeksjoner med immunmodulatorforbindelse
SE0200198D0 (sv) New use
WO2005084315A3 (en) Pyranoindole derivatives and the use thereof for the treatment of hepatitis c virus infection or disease
NO20065518L (no) Behandling eller forebyggelse av respiratoriske virusinfeksjoner med immunmodulerende forbindelser.
WO2008030260A3 (en) Treatment of variola viral infections using a tissue factor inhibitor
WO2006076015A3 (en) 1-[2-(phosphonomethoxy)ethyl]-cytosine and analogs thereof
NO20055512L (no) Terapi eller prevensjon av respiratoriske, virale infeksjoner med alfa-tyimosinpeptider
CY1111067T1 (el) Χρηση της ν-(διβενζ (β,f) οξεπιν-10-υλμεθυλ) -ν-μεθυλ-ν-προπ-2-υνυλαμινης (omigapil) στην προληψη και/ή την θεραπεια της μυϊκης δυστροφiας
WO2010019698A3 (en) Inhibition of calicivirus (norovirus)
ATE420655T1 (de) Alpha-defensine als anthrax-immuntherapeutika
HK40104212A (en) Rock2 inhibitor for the treatment of viral infection
RU2007145646A (ru) Средство для лечения вич-инфекции

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application